There is no vaccine, and the disease causes the deaths of a million people annually in Africa alone.
Experts say 90 percent of malaria cases are in sub-Saharan Africa.
About 550 million people in the African region risk the disease.
The conference this week in Abuja, Nigeria, is sponsored by the World Health Organization and will draw together U.N. agencies, the World Bank, Western donors and the heads of 20 African countries in a Roll Back Malaria campaign that hopes to halve deaths from malaria, a mosquito-borne disease, within 10 years.
In fact, Ruebush said, 90 percent of all malaria infections and 90 percent of malaria deaths occur in Africa.
In spite of drug resistance, malaria is a curable disease, it said, adding that research and development in malaria prevention and treatment have made advances.
Both the organization's book International Travel and Health ; Vaccination Requirements and Health Advice and the CDC's Health Information for International Travel list the countries requiring the certificate, but those requirements are based on whether a traveler has recently been in a yellow fever area.
But researchers from the U.S. Centers for Disease Control and Prevention and from India have created a multipronged vaccine designed to make the immune system fight the parasite at many stages : When the mosquito bite sends it into the body, when it invades the liver and when infection moves into the bloodstream.
